IndraLab

Statements


UCHL1 deubiquitinates SMAD2. 2 / 3
1 | 2

reach
"UCHL1 promoted TGFβ-SMAD signaling by deubiquitinating the TGFβ type I receptor and SMAD2, resulting in enhanced metastasis [94]."

reach
"In a separate study using a DUB activity profiling approach Liu et al. identified UCHL1 as a particularly active DUB in TNBC, proposing that UCHL1 also promotes TGF-β-induced TNBC metastasises by deubiquitinating and stabilising TGFβR1 and SMAD2 [54]."